|
National Science and Technology Council Committee on STEM Education (CoSTEM) and Federal Coordination in STEM Education (FC-STEM)
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
OD/SWD
|
The Committee on STEM Education (CoSTEM) was established pursuant to the requirements of Section 101 of the America COMPETES Reauthorization Act of 2010 (42 U.S.C. §6621). In accordance with the Act, the Committee reviews science, technology, engineering, and mathematics (STEM) education programs, investments, and activities, and the respective assessments of each, in federal agencies to ensure that they are effective; coordinates, with the Office of Management and Budget, STEM education programs, investments, and activities throughout the federal agencies; and develops and implements through the participating agencies a STEM education strategic plan, to be updated every five years. The Federal Coordination in STEM Education Subcommittee (FC-STEM) is a subcommittee of the NSTC Committee on STEM Education (CoSTEM). FC-STEM advises and assists CoSTEM and serves as a forum to facilitate the formulation and implementation of the strategic plan. Dr. Marie A. Bernard, the NIH Chief Officer for Scientific Workforce Diversity, is the lead representative for the U.S. Department of Health and Human Services to the National Science and Technology Council Committee on STEM Education (CoSTEM) and its Federal Coordination in STEM Education (FC-STEM) subcommittee. Established in 2011 in alignment with the America COMPETES Reauthorization Act of 2010, CoSTEM coordinates federal programs and activities in support of STEM education and creates a strategic plan for STEM education every five years. FC-STEM advises and assists CoSTEM and is a forum to facilitate the strategic plan’s development and implementation.
|
|
National Sewage Surveillance Interagency Leadership committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIEHS
|
To facilitate federal coordination, the US Department of Health and Human Services (HHS) and CDC have convened the National Sewage Surveillance Interagency Leadership (NSSIL) Committee. NSSIL member agencies support CDC in developing and implementing the National Wastewater Surveillance System (NWSS) to collect, analyze, and integrate wastewater-based COVID-19 data with COVID-19 case and syndromic data to assist state and local partners to make response decisions.
|
|
National Strategy for Suicide Prevention Interagency Work Group
|
Committee, Work group, Advisory group, or Task Force
|
SAMHSA, ASPE, CDC
|
NIMH
|
The federal Interagency Work Group (IWG) helped develop the new National Strategy for Suicide Prevention. This IWG is comprised of over 20 agencies in 10 federal departments across the government, with support from the Suicide Prevention Resource Center (SPRC), the National Action Alliance for Suicide Prevention (Action Alliance), and a project management team co-led by officials at the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Centers for Disease Control and Prevention (CDC), alongside the National Institute of Mental Health (NIMH) and the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Planning and Evaluation (ASPE/HHS).
|
|
National Survey of Family Growth
|
Health Survey
|
ACF, CDC
|
NICHD
|
The National Survey of Family Growth (NSFG) gathers information on family life, marriage and divorce, pregnancy, infertility, use of contraception, and men’s and women’s health. The survey results are used by the US Department of Health and Human Services and others to plan health services and health education programs and to do statistical studies of families, fertility, and health. The NSFG is used by: scholars in the behavioral sciences (e.g., sociology, demography, and economics) to study marriage, divorce, fertility, and family life; scholars in public health to study reproductive, maternal and infant health topics; agencies of the US Department of Health and Human Services to brief senior officials and to inform program decision-making; in research programs and in health and social service programs; state and local governments to plan health and social service programs; and the press, to prepare articles on a number of topics related to health and family life. https://www.cdc.gov/nchs/nsfg/index.htm
|
|
National Teen Mental Health Essay Contest
|
Other
|
AHRQ, CDC, FDA, HRSA, SAMHSA, USPHS
|
NIMHD
|
The essay contest challenges high school students ages 16-18 to raise awareness of mental health. The contest gives students a platform to share ways to eliminate and/or reduce mental health stigma faced by young people, especially in diverse communities.
|
|
National Toxicology Board of Scientific Counselors
|
Committee, Work group, Advisory group, or Task Force
|
OASH, CDC, FDA
|
NIEHS
|
A federally chartered external advisory committee whose members are appointed by the Secretary of Health and Human Services
|
|
National Toxicology Program Executive Committee
|
Committee, Work group, Advisory group, or Task Force
|
ATSDR, CDC, FDA
|
NCI, NIEHS
|
An internal government group comprised of heads (or designees) of HHS (NCEH/ATSDR, FDA, NCI, NIEHS, NIOSH) and non-HHS (CPSC, DoD, EPA, OSHA) agencies
|
|
National Toxicology Program Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
ATSDR, CDC, FDA
|
NIEHS
|
An internal government group comprised of the principal agencies of the National Toxicology Program
|
|
National Vaccine Advisory Committee (NVAC)
|
Committee, Work group, Advisory group, or Task Force
|
OASH
|
NIAID
|
The National Vaccine Advisory Committee (NVAC) recommends ways to achieve optimal prevention of human infectious diseases through vaccine development and provides direction to prevent adverse reactions to vaccines. This advice is presented to the Assistant Secretary for Health who serves as the Director of National Vaccine Program on matters related to program responsibilities.
|
|
Natural History Studies and Registries in the Development of Rare Disease Treatments Workshop
|
Meeting/ Workshop
|
FDA
|
NCATS
|
NCATS worked with the FDA and the Reagan-Udall Foundation for the FDA to host a hybrid public workshop on May 13, 2024, to bring together rare disease patient advocates, academic researchers, regulated industry, and other key communities to discuss considerations for the use of natural history studies and registry data in rare disease drug development programs. This workshop addresses the role and design of registries and natural history studies to inform the development of rare disease treatments, including aspects of clinical trial design; collecting registry and natural history data that are fit for regulatory purposes; and the use of registries and natural history studies to inform regulatory decision-making.
|